Balchem (BCPC) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

BCPC Stock Forecast

Balchem stock forecast is as follows: an average price target of $190.00 (represents a 15.04% upside from BCPC’s last price of $165.16) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

BCPC Price Target

The average price target for Balchem (BCPC) is $190.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $190.00 to $190.00. This represents a potential 15.04% upside from BCPC's last price of $165.16.

BCPC Analyst Ratings

Buy

According to 2 Wall Street analysts, Balchem's rating consensus is 'Buy'. The analyst rating breakdown for BCPC stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Balchem Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 05, 2024	Raghuram Selvaraju	H.C. Wainwright	$190.00	$175.31	8.38%	15.04%
May 02, 2022		H.C. Wainwright	$152.00	$123.20	23.38%	-7.97%

The latest Balchem stock forecast, released on Nov 05, 2024 by Raghuram Selvaraju from H.C. Wainwright, set a price target of $190.00, which represents a 8.38% increase from the stock price at the time of the forecast ($175.31), and a 15.04% increase from BCPC last price ($165.16).

Balchem Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	1
Avg Price Target	-	$190.00	$190.00
Last Closing Price	$165.16	$165.16	$165.16
Upside/Downside	-100.00%	15.04%	15.04%

In the current month, the average price target of Balchem stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Balchem's last price of $165.16. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
May 06, 2024	H.C. Wainwright	Buy	Buy	Hold
Oct 30, 2023	UBS	Buy	Buy	Hold

Balchem's last stock rating was published by H.C. Wainwright on May 06, 2024. The company gave BCPC a "Buy" rating, the same as its previous rate.

Balchem Financial Forecast

Balchem Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$229.95M	$231.25M	$232.54M	$232.53M	$244.27M	$236.69M	$228.87M	$213.13M	$197.87M	$202.37M	$185.66M	$180.71M	$175.14M	$173.35M	$174.44M	$166.53M	$158.59M
Avg Forecast	$295.34M	$288.60M	$282.02M	$275.58M	$265.20M	$261.84M	$255.92M	$249.46M	$239.96M	$241.93M	$239.68M	$232.46M	$234.66M	$237.08M	$244.87M	$233.52M	$241.47M	$239.62M	$223.53M	$207.69M	$198.17M	$196.13M	$185.44M	$181.59M	$175.33M	$169.55M	$161.35M	$169.87M	$165.55M	$167.43M
High Forecast	$301.09M	$294.22M	$287.51M	$280.95M	$270.37M	$266.93M	$260.90M	$254.01M	$246.67M	$242.17M	$239.68M	$236.98M	$238.64M	$242.50M	$249.63M	$238.07M	$246.17M	$239.62M	$223.53M	$207.69M	$198.17M	$196.13M	$185.44M	$181.59M	$175.33M	$169.55M	$161.35M	$169.87M	$165.55M	$167.43M
Low Forecast	$291.12M	$284.47M	$277.98M	$271.64M	$261.41M	$258.09M	$252.26M	$244.91M	$233.24M	$241.69M	$239.68M	$229.13M	$230.68M	$234.30M	$241.36M	$230.18M	$238.01M	$239.62M	$223.53M	$207.69M	$198.17M	$196.13M	$185.44M	$181.59M	$175.33M	$169.55M	$161.35M	$169.87M	$165.55M	$167.43M
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	2	3	1	1	1	1	1	1	1	1	1	1	1	3	3	3	2	2
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.97%	0.94%	1.00%	0.96%	1.02%	1.06%	1.10%	1.08%	1.01%	1.09%	1.02%	1.03%	1.03%	1.07%	1.03%	1.01%	0.95%

Balchem's average Quarter revenue forecast for Dec 23 based on 2 analysts is $234.66M, with a low forecast of $230.68M, and a high forecast of $238.64M. BCPC's average Quarter revenue forecast represents a 2.05% increase compared to the company's last Quarter revenue of $229.95M (Sep 23).

Balchem EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	2	3	1	1	1	1	1	1	1	1	1	1	1	3	3	3	2	2
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$43.61M	$42.84M	$48.05M	$33.30M	$48.82M	$52.15M	$50.10M	$45.40M	$44.80M	$42.73M	$43.07M	$41.81M	$41.91M	$39.68M	$38.73M	$35.95M	$37.86M
Avg Forecast	$66.36M	$64.84M	$63.36M	$61.92M	$59.59M	$58.83M	$57.50M	$56.05M	$53.91M	$54.36M	$53.85M	$45.10M	$52.72M	$53.27M	$55.02M	$41.00M	$49.28M	$54.79M	$51.11M	$37.27M	$45.31M	$44.85M	$42.40M	$42.06M	$40.09M	$38.77M	$36.89M	$26.03M	$37.85M	$38.28M
High Forecast	$67.65M	$66.11M	$64.60M	$63.12M	$60.75M	$59.97M	$58.62M	$57.07M	$55.42M	$54.41M	$53.85M	$54.12M	$53.62M	$54.48M	$56.09M	$49.20M	$59.13M	$54.79M	$51.11M	$44.73M	$45.31M	$44.85M	$42.40M	$50.47M	$40.09M	$38.77M	$36.89M	$31.24M	$37.85M	$38.28M
Low Forecast	$65.41M	$63.92M	$62.46M	$61.03M	$58.73M	$57.99M	$56.68M	$55.03M	$52.40M	$54.30M	$53.85M	$36.08M	$51.83M	$52.64M	$54.23M	$32.80M	$39.42M	$54.79M	$51.11M	$29.82M	$45.31M	$44.85M	$42.40M	$33.65M	$40.09M	$38.77M	$36.89M	$20.83M	$37.85M	$38.28M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.82%	0.78%	1.17%	0.68%	0.89%	1.02%	1.34%	1.00%	1.00%	1.01%	1.02%	1.04%	1.08%	1.08%	1.49%	0.95%	0.99%

2 analysts predict BCPC's average Quarter EBITDA for Dec 23 to be $52.72M, with a high of $53.62M and a low of $51.83M. This is 20.89% upper than Balchem's previous annual EBITDA (Sep 23) of $43.61M.

Balchem Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	2	3	1	1	1	1	1	1	1	1	1	1	1	3	3	3	2	2
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$29.07M	$30.11M	$22.71M	$21.41M	$25.25M	$29.78M	$28.93M	$24.95M	$25.01M	$22.73M	$23.41M	$22.16M	$21.57M	$21.13M	$19.77M	$20.38M	$20.68M
Avg Forecast	$42.29M	$42.95M	$42.29M	$41.31M	$39.34M	$40.00M	$39.67M	$39.01M	$36.23M	$36.55M	$33.93M	$26.04M	$30.49M	$31.80M	$27.54M	$23.67M	$27.08M	$30.53M	$30.69M	$21.52M	$25.47M	$27.43M	$26.77M	$22.86M	$22.36M	$21.63M	$18.17M	$13.29M	$22.53M	$21.55M
High Forecast	$43.36M	$44.03M	$43.36M	$42.35M	$40.34M	$41.01M	$40.67M	$41.08M	$37.14M	$37.48M	$34.79M	$31.25M	$31.19M	$34.42M	$28.23M	$28.41M	$32.49M	$30.53M	$30.69M	$25.83M	$25.47M	$27.43M	$26.77M	$27.43M	$22.36M	$21.63M	$18.17M	$15.94M	$22.53M	$21.55M
Low Forecast	$41.50M	$42.15M	$41.50M	$40.54M	$38.61M	$39.25M	$38.93M	$36.60M	$35.90M	$35.87M	$33.30M	$20.83M	$29.79M	$29.18M	$27.03M	$18.94M	$21.66M	$30.53M	$30.69M	$17.22M	$25.47M	$27.43M	$26.77M	$18.29M	$22.36M	$21.63M	$18.17M	$10.63M	$22.53M	$21.55M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.91%	1.09%	0.96%	0.79%	0.83%	0.97%	1.34%	0.98%	0.91%	0.85%	1.02%	0.99%	1.00%	1.16%	1.49%	0.90%	0.96%

Balchem's average Quarter net income forecast for Dec 23 is $30.49M, with a range of $29.79M to $31.19M. BCPC's average Quarter net income forecast represents a 4.86% increase compared to the company's last Quarter net income of $29.07M (Sep 23).

Balchem SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	2	3	1	1	1	1	1	1	1	1	1	1	1	3	3	3	2	2
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$29.06M	$30.72M	$35.31M	$32.29M	$31.81M	$29.03M	$29.94M	-	$25.27M	$25.95M	$25.40M	$25.52M	$24.65M	$25.89M	$26.35M	$27.77M	$25.28M
Avg Forecast	$41.14M	$40.20M	$39.28M	$38.39M	$36.94M	$36.47M	$35.65M	$34.75M	$33.42M	$33.70M	$33.38M	$26.95M	$32.69M	$33.02M	$34.11M	$24.50M	$33.63M	$32.27M	$30.11M	$22.27M	$26.69M	$26.42M	$24.98M	$24.81M	$23.61M	$22.84M	$21.73M	$17.71M	$22.30M	$22.55M
High Forecast	$41.94M	$40.98M	$40.05M	$39.13M	$37.66M	$37.18M	$36.34M	$35.38M	$34.36M	$33.73M	$33.39M	$32.34M	$33.24M	$33.78M	$34.77M	$29.40M	$34.29M	$32.27M	$30.11M	$26.73M	$26.69M	$26.42M	$24.98M	$29.77M	$23.61M	$22.84M	$21.73M	$21.26M	$22.30M	$22.55M
Low Forecast	$40.55M	$39.62M	$38.72M	$37.84M	$36.41M	$35.95M	$35.14M	$34.11M	$32.49M	$33.66M	$33.38M	$21.56M	$32.13M	$32.63M	$33.62M	$19.60M	$33.15M	$32.27M	$30.11M	$17.82M	$26.69M	$26.42M	$24.98M	$19.84M	$23.61M	$22.84M	$21.73M	$14.17M	$22.30M	$22.55M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.88%	0.90%	1.44%	0.96%	0.99%	0.96%	1.34%	-	0.96%	1.04%	1.02%	1.08%	1.08%	1.19%	1.49%	1.25%	1.12%

Balchem's average Quarter SG&A projection for Dec 23 is $32.69M, based on 2 Wall Street analysts, with a range of $32.13M to $33.24M. The forecast indicates a 12.47% rise compared to BCPC last annual SG&A of $29.06M (Sep 23).

Balchem EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	2	3	1	1	1	1	1	1	1	1	1	1	1	3	3	3	2	2
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$0.91	$0.94	$0.71	$0.67	$0.79	$0.93	$0.90	$0.77	$0.78	$0.70	$0.73	$0.68	$0.67	$0.66	$0.62	$0.63	$0.64
Avg Forecast	$1.29	$1.31	$1.29	$1.26	$1.20	$1.22	$1.21	$1.19	$1.10	$1.11	$1.03	$0.98	$0.93	$0.97	$0.84	$0.72	$0.80	$0.94	$0.94	$0.82	$0.78	$0.84	$0.82	$0.79	$0.69	$0.66	$0.56	$0.62	$0.69	$0.66
High Forecast	$1.32	$1.34	$1.32	$1.29	$1.23	$1.25	$1.24	$1.25	$1.13	$1.14	$1.06	$1.00	$0.95	$1.05	$0.86	$0.74	$0.82	$0.94	$0.94	$0.82	$0.78	$0.84	$0.82	$0.79	$0.69	$0.66	$0.56	$0.62	$0.69	$0.66
Low Forecast	$1.27	$1.29	$1.27	$1.24	$1.18	$1.20	$1.19	$1.12	$1.10	$1.09	$1.02	$0.96	$0.91	$0.89	$0.82	$0.71	$0.79	$0.94	$0.94	$0.82	$0.78	$0.84	$0.82	$0.79	$0.69	$0.66	$0.56	$0.62	$0.69	$0.66
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.94%	1.12%	0.99%	0.84%	0.84%	0.99%	1.10%	0.99%	0.93%	0.86%	0.92%	1.00%	1.01%	1.19%	1.00%	0.92%	0.97%

According to 2 Wall Street analysts, Balchem's projected average Quarter EPS for Dec 23 is $0.93, with a low estimate of $0.91 and a high estimate of $0.95. This represents a 2.20% increase compared to BCPC previous annual EPS of $0.91 (Sep 23).

Balchem Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
KWR	Quaker Chemical	$140.33	$195.00	38.96%	Buy
CBT	Cabot	$91.68	$127.00	38.53%	Hold
ASH	Ashland	$71.57	$94.25	31.69%	Buy
AXTA	Axalta Coating Systems	$34.37	$44.14	28.43%	Buy
FUL	H.B. Fuller	$67.63	$85.60	26.57%	Buy
SXT	Sensient	$72.18	$85.00	17.76%
MTX	Minerals	$76.87	$90.00	17.08%	Buy
BCPC	Balchem	$165.16	$190.00	15.04%	Buy

BCPC Forecast FAQ

Is Balchem a good buy?

Yes, according to 2 Wall Street analysts, Balchem (BCPC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of BCPC's total ratings.

What is BCPC's price target?

Balchem (BCPC) average price target is $190 with a range of $190 to $190, implying a 15.04% from its last price of $165.16. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Balchem stock go up soon?

According to Wall Street analysts' prediction for BCPC stock, the company can go up by 15.04% (from the last price of $165.16 to the average price target of $190), up by 15.04% based on the highest stock price target, and up by 15.04% based on the lowest stock price target.

Can Balchem stock reach $200?

BCPC's average twelve months analyst stock price target of $190 does not support the claim that Balchem can reach $200 in the near future.

What are Balchem's analysts' financial forecasts?

Balchem's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.03B (high $1.05B, low $1.02B), average EBITDA is $231.96M (high $236.41M, low $228.43M), average net income is $158.01M (high $163.1M, low $153.38M), average SG&A $143.8M (high $146.56M, low $141.61M), and average EPS is $4.82 (high $4.98, low $4.68). BCPC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.14B (high $1.16B, low $1.13B), average EBITDA is $256.48M (high $261.48M, low $252.82M), average net income is $168.83M (high $173.1M, low $165.69M), average SG&A $159M (high $162.1M, low $156.73M), and average EPS is $5.15 (high $5.28, low $5.05).

Did the BCPC's actual financial results beat the analysts' financial forecasts?

Based on Balchem's last annual report (Dec 2022), the company's revenue was $942.36M, beating the average analysts forecast of $912.31M by 3.29%. Apple's EBITDA was $197.03M, beating the average prediction of $192.45M by 2.38%. The company's net income was $105.37M, missing the average estimation of $109.82M by -4.05%. Apple's SG&A was $123.07M, beating the average forecast of $118.28M by 4.05%. Lastly, the company's EPS was $3.29, missing the average prediction of $3.49 by -5.87%. In terms of the last quarterly report (Sep 2023), Balchem's revenue was $229.95M, missing the average analysts' forecast of $237.08M by -3.01%. The company's EBITDA was $43.61M, missing the average prediction of $53.27M by -18.12%. Balchem's net income was $29.08M, missing the average estimation of $31.8M by -8.57%. The company's SG&A was $29.06M, missing the average forecast of $33.02M by -11.99%. Lastly, the company's EPS was $0.91, missing the average prediction of $0.97 by -6.19%